Cardinal Health acquires AdaptHealth's Diabetes Health and Strive Medical for $360 million

The 8-K filing shows Diabetes Health assets sold for 235.0 million in cash, with escrow of 8.0 million for post-closing working capital adjustments and 18.8 million for indemnification obligations, and the closing is subject to Hart-Scott-Rodino review and other customary conditions.
Several outlets reported a total value of about 360 million in cash for the AdaptHealth assets (Diabetes Health and Strive Medical), while the official 8-K discloses 235 million for Diabetes Health alone, indicating a mismatch in reported deal size across sources.
Cardinal Health has already migrated all Advanced Diabetes Supply volume onto its distribution network and onboarded nearly 500,000 new customers since that acquisition closed, expanding its home-care platform.
The Diabetes Health business uses a centralized mail-order model to deliver diabetes management supplies directly to patients, including continuous glucose monitors.
AdaptHealth CEO Suzanne Foster described the divestiture as the latest step in a deliberate, multi-year effort to focus on AdaptHealth's core sleep, respiratory and supporting home medical equipment businesses, crossing the threshold of the home to deliver clinical value to patients.
Cardinal Health has agreed to buy AdaptHealth's Diabetes Health business and Strive Medical for about $360 million in cash, according to Yahoo Finance. The deal expands Cardinal Health's at-Home Solutions platform and adds more than 225,000 diabetes patients served annually through a mail-order model.
The official 8-K filing, reported by GuruFocus, shows the Diabetes Health unit alone is priced at $235 million — suggesting Strive Medical accounts for the remaining roughly $125 million of the total deal value.
The Diabetes Health business uses a centralized mail-order model to ship diabetes supplies — including continuous glucose monitors — directly to patients at home. It serves more than 225,000 patients each year, according to Mahoning Matters.
Strive Medical is a smaller deal. It provides home medical supplies for wound care, urology, ostomy, and incontinence. It serves more than 20,000 patients per year. Together, the two acquisitions push Cardinal Health deeper into the home-care market.
AdaptHealth CEO Suzanne Foster called the sale "the latest step in a deliberate, multi-year effort" to focus on the company's core sleep, respiratory, and home medical equipment businesses. The company wants to concentrate on "crossing the threshold of the home to deliver clinical value to patients."
The divestiture fits AdaptHealth's broader strategy of stripping away non-core units. Selling Diabetes Health and Strive Medical lets the company sharpen its focus while converting those assets into cash.
Cardinal Health has already been expanding its home-care reach. The company migrated all Advanced Diabetes Supply volume onto its distribution network after a prior acquisition. It has onboarded nearly 500,000 new customers since that deal closed, according to 740 The Fan.
This new deal layers on top of that foundation. Cardinal Health's executives described the acquisitions as a natural extension of its at-Home Solutions strategy — adding patients, product categories, and scale in one move.
The 8-K filing details specific financial guardrails for the Diabetes Health portion. Cardinal Health will place $8 million in escrow for post-closing working capital adjustments and $18.8 million for indemnification obligations, according to GuruFocus.
The deal still needs to clear Hart-Scott-Rodino antitrust review and other standard regulatory approvals before it can close. Cardinal Health says both acquisitions are expected to add to non-GAAP earnings per share in the first full year after closing.
Publishers
10
Articles
100
Reach
110